000			01951 a2200517 4500
005			20250513030617.0
264		0	_c19940207
008			199402s 0 0 eng d
022			_a0268-3369
040			_aNLM _beng _cNLM
100	1		_aKlumpp, T R
245	0	0	_aPhase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. _h[electronic resource]
260			_bBone marrow transplantation _cOct 1993
300			_a337-45 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBlood Component Transfusion
650	0	4	_aBone Marrow Transplantation
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGranulocyte Colony-Stimulating Factor _xtherapeutic use
650	0	4	_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHodgkin Disease _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aLife Tables
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aSurvival Analysis
700	1		_aMangan, K F
700	1		_aGlenn, L D
700	1		_aMalaspina, D R
700	1		_aCropper, T
700	1		_aMullaney, M
700	1		_aMacdonald, J S
773	0		_tBone marrow transplantation _gvol. 12 _gno. 4 _gp. 337-45
999			_c7505559 _d7505559